About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, August 26th, 2014

The QualityStocks
Daily Stock List

graphic
graphic

Reflect Scientific, Inc. (RSCF)

Wall Street Corner, Real Pennies, and Emerging Markets reported on Reflect Scientific, Inc. (RSCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Reflect Scientific, Inc. develops and markets innovative, proprietary technologies in cryogenic cooling. These are for the healthcare, biotechnology, pharmaceutical, medical, industrial, as well as transportation markets. The Company’s products include low-temperature freezers and refrigerated containers for laboratory and transportation uses. Reflect Scientific has its headquarters in Orem, Utah. 

The Company continues to center its efforts on increasing the sales of its life science consumables and detectors while, at the same time, working to commercialize its liquid nitrogen refrigeration products. The refrigerated trailer, called a "reefer", is receiving highest priority. Reflect Scientific has its first manufactured unit operational, has conducted several road tests, and is presently analyzing the data collected to validate its efficiency and reliability.

In addition, the Company continues to concentrate on the expansion of its detector line and developing alliances with contract manufacturers for its ultra-low temperature freezers and reefer units. Its new detector has enhanced functionality, and has a low cost. Reflect Scientific believes that this provides it with a competitive edge over products now selling in that specialized market. Reflect has completed its on-line catalog and is making progress in enrolling new distributors for its consumable products.

Reflect’s product lines include Cryometrix and Visacon. Cryometrix cooling and refrigeration products use a pioneering liquid nitrogen technology. Liquid nitrogen means no compressors, no CFC’s, low energy usage and considerably reduced maintenance.

The Visacon brand’s focus is on providing the highest quality original equipment manufacturer (OEM) products for chromatography. Visacon offers quality products, from laboratory consumables to UV/VIS instrumentation. This brand has 17 years of providing chromatography products to the life sciences markets. Visacon’s specialty is custom manufacturing and packaging.

Reflect Scientific’s revenues during the three and six month reporting periods increased 28 percent and 38 percent, respectively during 2014 versus 2013 revenues. Revenues increased during the quarter ended June 30, 2014, to $378,913 from $296,281 for the quarter ended June 30, 2013. This represents an increase of $82,642. The net loss for the three month period ended June 30, 2014 was $19,362. This is an improvement of $68,313 from the $87,675 loss for the three month period ended June 30, 2013.

Reflect Scientific, Inc. (RSCF), closed Tuesday's trading session at $0.10, even for the day, on 121,455 volume with 2 trades. The average volume for the last 60 days is 21,636 and the stock's 52-week low/high is $0.05/$0.105.

Telik, Inc. (TELK)

Gryphon Digest, The Street, and The Trading Report reported earlier on Telik, Inc. (TELK), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Telik, Inc. is a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014. MabVax Therapeutics is now the wholly-owned subsidiary and primary business unit of Telik. MabVax Therapeutics is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. The post-merger company is now evaluating development programs taking place at Telik before the merger, in addition to plans to continue developing the existing pipeline at MabVax. Telik’s shares trade on the OTC Markets’ OTCQB.

MabVax Therapeutics has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. Therapeutic vaccines under development were discovered at Memorial Sloan-Kettering Cancer Center (MSKCC) and are exclusively licensed to MabVax Therapeutics before the above-mentioned merger.

Yesterday, Telik announced that it received a $1.5 million contract for the Phase 2 portion of a Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI). The intention of the contract is to support a major portion of the preclinical work being conducted by MabVax, together with its collaboration partner, MSKCC to develop a novel Positron Emission Tomography (PET) imaging agent for detection and assessment of pancreatic cancer.

This month, MabVax Therapeutics and MSKCC completed the Phase 1 of the SBIR contract by successfully demonstrating the feasibility of the project enabling the follow-on contract award. The research contract accrues to Telik because of the July 2014 merger with MabVax Therapeutics.

Telik generates its pipeline of antibody based product candidates from patients who have been vaccinated with the proprietary vaccines the Company has licensed from MSKCC.  Telik’s unique approach of surveying the protective immune response from numerous patients to identify the ideal monoclonal antibody candidate against a specific target on the surface of a cancer cell is a novel next-generation human antibody technology platform. 

Telik, Inc. (TELK), closed Tuesday's trading session at $1.00, even for the day, on 21,867 volume with 23 trades. The average volume for the last 60 days is 22,688 and the stock's 52-week low/high is $0.6802/$2.15.

Rocap Marketing, Inc. (ROCP)

Greenbackers reported earlier on Rocap Marketing, Inc. (ROCP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rocap Marketing, Inc. on July 1, 2014, acquired 100 percent ownership of Spiral, LLC, which designs and distributes online entertainment applications. Spiral Toys was incorporated in 2011 in Los Angeles, California.  It has centered on entertaining the younger generation of consumers on mobile smart devices and connected technologies. Spiral has developed an innovative, low-cost platform that connects physical toys and merchandise to mobile smart devices. Rocap Marketing’s shares trade on the OTC Bulletin Board. The Company is based in Los Angeles, California.

Spiral has developed an integrated hardware/software/cloud solution that enables mobile-connected entertainment as part of its user experience. These products utilize its ground-breaking ToyCloud platform. Spiral Toys creates new play experiences for consumers of all ages through developing digital platforms and hardware that connect physical toys and devices to the interactive digital world.

Furthermore, Spiral’s new line of ToyCloud enabled products connects physical toys to Apple and Android devices via Spiral's proprietary Bluetooth Smart technology and cloud-based services. By using ToyCloud, children and parents can send and receive messages, play collaborative games, and read interactive stories by merging traditional behaviors with new play patterns. Spiral launched the sale of its initial product line Toy-Fi in June of this year.

The Company’s first initial orders were released in two test markets, the United Kingdom and Australia. Initial shipments totaled more than 60,000 units of Toy-Fi product, which is a teddy bear enabled with Spiral technology, with a retail price of between $29.95 and $39.95. Spiral (as a licensee of the technology) will be paid royalty payments. Spiral is also developing digital content available for purchase on the Apple APP store and Google Marketplace.

On July 22, 2014, Rocap announced that it completed the acquisition of Spiral Toys, Inc. After the acquisition of Spiral Toys, Rocap Marketing divested Lexi Luu Designs, Inc., in a move that further defines Rocap’s new direction.

Rocap Marketing, Inc. (ROCP), closed Tuesday's trading session at $0.50, even for the day. The average volume for the last 60 days is 3,834 and the stock's 52-week low/high is $0.20/$0.60.

LabStyle Innovations Corp. (DRIO)

TheMicrocapNews, Streetwise Reports, PennyStocks24, StockOnion, Penny Pick Finders, Planet Penny Stocks, Buzz Stocks, PennyStockProphet, and StreetInsider reported on LabStyle Innovations Corp. (DRIO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

LabStyle Innovations Corp. is the developer of Dario™, a cloud-based, mobile health platform for diabetes and blood glucose monitoring. Its flagship product is the Dario™ Diabetes Management Solution.  The Company is a mobile health (mHealth) enterprise developing and commercializing patent-pending technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle Innovations established with a mission to advance the way consumers engage, monitor, and lead healthier lives via the commercialization of innovative, self-diagnostic technologies and platforms. The Company’s shares trade on the OTC Markets’ OTCQB.

Dario™ received CE mark certification in September of 2013. The Company is pursuing patent applications in many areas covering the specific processes related to blood glucose level measurement and more general methods of rapid tests of body fluids using mobile devices and cloud-based services. LabStyle filed a Premarket Notification Application (a 510(k)), with the U.S. Food and Drug Administration (FDA) for the Dario™ smart meter (Dario™ Blood Glucose Monitoring System) in December of 2013. 

The Dario™ diabetes management platform includes the novel Dario™ app, website software, and an 'all-in-one', pocket-sized, Dario™ blood glucose monitoring device that comes complete with lancet, strips and a glucose meter. The glucose meter connects to a smartphone and the feature rich Dario™ mobile and website applications. This enables patients, medical professionals, and caregivers to access and analyze data in real time and from histories. 

LabStyle Innovations' worldwide roll-out of the Dario™ diabetes management platform began on December 12, 2013 with the market launch of the Dario™ iOS app in the United Kingdom (UK), Australia and New Zealand. The Dario™ iOS app is available in these countries for free download.

Recently, LabStyle Innovations announced that it has released the Dario™ Diabetes Management App for Android smartphone users.  The mobile application will have the same user interface and features as the iOS Dario™ Application. It will be available in select soft launch markets. This includes the UK and New Zealand.

LabStyle Innovations Corp. (DRIO), closed Tuesday's trading session at $0.073, down 9.20%, on 31,199,905 volume with 1,652 trades. The average volume for the last 60 days is 1,617,614 and the stock's 52-week low/high is $0.05/$3.00.

3DX Industries, Inc. (DDDX)

Real Pennies reported earlier on 3DX Industries, Inc. (DDDX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

3DX Industries, Inc. focuses on the additive metal manufacturing segment within the manufacturing industry. The Company can manufacture a broad array of products using its three-dimensional (3D) metal printing system, 3D composite printing, and more traditional methods of precision manufacturing.  The Company previously went by the name Amarok Resources, Inc. It changed its corporate name to 3DX Industries, Inc. in November of 2013. 3DX Industries has its head office in Ferndale, Washington. The Company lists on the OTCQB.

3DX Industries offers additive and traditional manufacturing services as well as product design, engineering and assembly services to its customers. This past May, the Company announced that it completed its first series of production run components using the M-Flex™ Metal Printing System manufactured by The ExOne Company. ExOne is an international provider of 3D printing machines and printed products to industrial customers. Its present workload consists of proto-type and production run parts for diverse industries. This includes agriculture, green energy generation, food processing and other industrial components now in use by its clients.

3DX Industries has now printed many 3D Metal components and parts for clients’ use. It continues to produce 3D metal printed parts using the M-Flex™ Metal Printing System manufactured by ExOne.

3DX's M-Flex™ metal printing system from ExOne employs an additive manufacturing process. This is known as three-dimensional printing, or 3DP. It materializes an object—or mold for an object—layer by layer out of powdered material, a chemical binder and a digital file. The process is also called Binder Jetting Technology.

With 3D Metal Printing, 3DX Industries helps its customers save material cost and weight for prototyping and short run productions.  The Company can make a customer’s proto-type or production run items efficiently, cost effectively, and on time using the latest 3D Metal printing technology with 3DX’s M-Flex 3D Metal printer, its Z-Corp Composite Printer or through its in-house precision machine shop.

3DX Industries, Inc. (DDDX), closed Tuesday's trading session at $1.13, up 25.56%, on 348,473 volume with 199 trades. The average volume for the last 60 days is 20,295 and the stock's 52-week low/high is $0.051/$7.00.

graphic

The QualityStocks
Company Corner

graphic
graphic

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.30, up 7.03%. The stock’s average daily volume over the past 60 days is 5,006, and its 52-week low/high is $0.15/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. Begins Development of Lung Cancer Detection Device

Zenosense, Inc. Highlights Recent Media Coverage of MRSA

Zenosense, Inc. Provides Development Update

NutraNomics, Inc. (NNRX)

The QualityStocks Daily Newsletter would like to spotlight NutraNomics, Inc. (NNRX). Today, NutraNomics, Inc. closed trading at $0.0725, up 4.92%, on 42,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 25,268, and its 52-week low/high is $0.06/$1.48.

NutraNomics, Inc. (NNRX) is focused on the research and development of nutritional dietary supplements, skin and body care products and transdermal patches. In addition to creating formulas for hundreds of companies, the company has produced and branded its own product lines which are sold through retail and wholesale channels. Additionally the company private labels and does custom manufacturing for several supplement companies in national and international markets.

Nearly all vitamins currently on the market are isolated and/or synthetic. The human body doesn’t recognize these types of vitamins and as a result cannot absorb them because they are either missing critical nutritional components or are not food based. NutraNomics has rapidly grown its business over the past 18 years by offering superior food and plant-based products blended from the highest quality sources available for maximum bioavailability.

Today NutraNomics has sales teams in seven different countries promoting its diversified line of wholefood-based supplements, specialty formulas, and remedies. All facilities used to produce the gluten-free, non-GMO nutritional products are cGMP Compliant and FDA approved. To ensure the highest purity potency and quality, the company takes it another step forward by performing additional content testing on all raw materials used to manufacture its products.

NutraNomics is more than just a health supplement provider. As a company dedicated to supporting the worldwide community of people who want to live healthy, NutraNomics is making an impact on those who are suffering from various types of diseases that need specialized diet to enhance their lifestyle. To fulfill this mission NutraNomics has invested in clinical studies for controlling diabetes, heart disease and cancer with dietary supplements. Strong growth is anticipated to continue as the company continues to introduce cutting-edge products and taps into new markets. Disclaimer

NutraNomics, Inc. Company Blog

NutraNomics, Inc. News:

Nutranomics Whole Food Based Vitamins and Supplements Reports Increase in Wholesale & Retail Sales

Nutranomics Whole Food Based Vitamins and Supplements Available on Amazon.com

Nutranomics Whole Food Based Vitamins and Supplements Joins Forces With Stonegate

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.015, up 14.50%, on 225,624 volume with 21 trades. The stock’s average daily volume over the past 60 days is 870,930, and its 52-week low/high is $0.009/$0.96.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017

Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India

Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India

Infinite Group, Inc. (IMCI)

The QualityStocks Daily Newsletter would like to spotlight Infinite Group, Inc. (IMCI). Today, Infinite Group, Inc. closed trading at $0.04, up 0.25%, on 1,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 20,587, and its 52-week low/high is $0.021/$0.17.

Infinite Group, Inc. (IMCI) professionals plan, integrate, manage and support complete IT solutions for customers in small to medium-sized businesses, government agencies and large commercial enterprises. Dedicated to quality and customer service, the company’s team of over 80 IT specialists is experienced in their individual fields and maintains the latest certifications. Infinite Group also partners with industry leaders such as VMware, HP, Microsoft, Cisco, and Dell to ensure its customers receive the best combination of products and services designed for their specific needs.

The company’s scalable solutions cover the entire IT chain, including consulting and project management, data storage and recovery solutions, IT security, managed services, and complete IT system development. Providing customers a single point of contact for all their IT needs, Infinite Group helps companies focus on their core business by improving IT efficiencies, reducing capital expenditures, and enjoying significant savings on operational costs.

Based in the Rochester, New York area, the company leverages its deep roots in technology to be one of today’s premier IT service and support suppliers. The company’s IT professionals provide on-site support to customers around the world and serve some of the premiere businesses and government organizations in the United States and worldwide including the U.S. Post Office, PepsiCo, Inc., the State of Mississippi, Home Depot, NASA, PricewaterhouseCoopers, the Florida Department of Financial Services, the U.S. Air Force, Navy, Army, and others. Personnel are located throughout the U.S. including Colorado Springs, Springfield and Vienna, Virginia and Washington, D.C. for added government support.

The IT services industry generates $500 billion in annual revenues and continues to grow as businesses progressively rely on technology to maintain operations and increase efficiency. With decades of experience and technical knowledge, and guided by the highest governance and business conduct guidelines, Infinite Group’s leadership team meets current and future business demands with expertise and effectiveness. Disclaimer

Infinite Group, Inc.Company Blog

Infinite Group, Inc.News:

Infinite Group, Inc. Announces Exclusive Government Channel Partner Agreement for Content Management Tools

Infinite Group, Inc. Partners With Unitrends to Provide Data Protection

Cybersecurity on Infinite Group, Inc.'s Radar With New Hire

Oriens Travel and Hotel Management Corp. (OTHM)

The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0002, even with yesterday's close, on 57,176,834 volume with 14 trades. The stock’s average daily volume over the past 60 days is 33,127,979, and its 52-week low/high is $0.0002/$0.0024.

Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Oriens has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Oriens Travel and Hotel Management Corp. Company Blog

Oriens Travel and Hotel Management Corp. News:

Oriens Provides Update on Finalization of Acquisition; Closing & Transfer of Asset

Oriens to Up-List

Oriens Engages PCAOB Auditor

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(LBAS)

2.

Wealth Daily
(DDDX)

3.

StockRockandRoll
(DROP)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251